Font Size Reduce Text Size Enlarge Text Size     Print Print     Download Reader PDF

This is an archive page. The links are no longer being updated.

FOR IMMEDIATE RELEASE
Friday, Oct. 22, 1999
Contact: Damon Thompson
(202) 205-1842

HHS ANNOUNCES PLANS TO IMPROVE RESEARCH INTEGRITY
AND PREVENT RESEARCH MISCONDUCT


HHS Secretary Donna E. Shalala today announced she has accepted the recommendations of a special review group on research misconduct and research integrity involving research funded by agencies of the U.S. Public Health Service.

The recommendations include a more precise and useful definition of research misconduct, which is being adopted by agencies throughout the federal government. They are also aimed at improving the process for investigating allegations of misconduct, and at expanding educational efforts to prevent misconduct.

"The vast majority of PHS-funded research is conducted by scientists who maintain the highest level of integrity," Secretary Shalala said. "However, in those rare instances when misconduct may be involved, we must have a process that responds as quickly and as fairly as possible."

Under the proposals agreed to by the Secretary today:

The review group's report recommends clarifying and refining the definition of research misconduct by limiting misconduct to "fabrication, falsification, or plagiarism in proposing, performing or reviewing research, or in reporting research results." Other types of misconduct (e.g. theft, harassment, discrimination) that might occur in the course of research are addressed through other laws and regulations.

ORI will continue to provide on-site technical assistance to institutional investigations where needed and oversight review of completed investigations. However, the review group recommended that the role and structure of ORI be changed to focus more on preventing misconduct and promoting research integrity through expanded education programs. The review group also encouraged the Department to develop consortia of third-party groups to perform investigations for those institutions that cannot or choose not to conduct their own. ORI will conduct a feasibility study on the use of such consortia during the coming year.

While some policy changes will occur immediately, the review group estimated that a one-year transition period would be necessary to fully restructure the Department's processes for addressing alleged or suspected research misconduct. Statutory and regulatory changes will be needed to implement the group's recommendations.

###


Note: For other HHS Press Releases and Fact Sheets pertaining to the subject of this announcement, please visit our Press Release and Fact Sheet search engine at: www.os.dhhs.gov/news/press/.